Effect of hepatitis C virus infection on the right ventricular functions, pulmonary arterypressure and pulmonary vascular resistance

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 8, 2014, Pages 2314-2318

  Demir, Canan ^a   Demir, Mehmet ^b  

^a Bursa Sevket Yilmaz Education and Research Hospital   (Turkey)

^b BURSA YUKSEK IHTISAS TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Cardiomyopathy; Hepatitis C virus; Myocarditis; Pulmonary artery pressure; Pulmonary vascular resistance

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HEPATITIS C; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; M MODE ECHOCARDIOGRAPHY; MALE; PHYSICAL EXAMINATION; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84907223065     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Zignego AL, Brechot C. Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol 1999; 31: 369-76.
2. Matsumori A. Symposium on clinical aspects in hepatitis virus infection. 5. Clinical practice of hepatitis: myocardial diseases, nephritis, and vasculitis associated with hepatitis virus. Intern Med 2001; 40: 182-4.
3. Amirzadegan A, Davoodi, Boroumand MA, Darabyan S, Dehkordi MR, Goodarzynejad H. Association between hepatitis B surface antibody seropositivity and coronary artery disease. Indian J Med Sci 2007; 61: 648-55.
4. Data Collection on Adverse Events of Anti-HIV Drugs (D: A: D) Study Group, Weber R, Sabin C, Reiss P, de Wit S, Worm SW, Law M, Dabis F, D'Arminio Monforte A, Fontas E, El-Sadr W, Kirk O, Rickenbach M, Phillips A, Ledergerber B, Lundgren J. HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals. Antivir Ther 2010; 15: 1077-86.
5. Demir M, Demir C. Effect of hepatitis B virus infection on right and left ventricular functions. Med Sci Monit 2012; 18: CR587-91.
6. Demir M, Demir C. Effect of hepatitis C virus infection on the left ventricular systolic and diastolic functions. South Med J 2011; 104: 543-6.
7. Aliannejad R, Ghanei M. Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis. Hepat Mon 2011; 11: 71-3.
8. Kanazawa H, Hirata K, Yoshikawa J. Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a prelimi nary study based on small numbers of patients. Chest 2003; 123: 596-9.
9. Matsumori A, Ohashi N, Sasayama S. Hepatitis C virus infection and hypertrophic cardiomyopathy. Ann Intern Med 1998; 129: 749-50.
10. Matsumori A, Matoba Y, Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 1995; 92: 2519-25.
11. Demir M, Demir C, Ülçay A. Effect of Hepatitis C Virus Infection on the Left Ventricular Hypertrophy. Turkiye Klinikleri J Cardiovasc Sci 2009; 21: 315-9.
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommen-dations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W; American Society of Echocardiography's Nomenclature and Standards Committee; Task-Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.
14. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the Ame-rican Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713.
15. Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ. A simple method for noninvasive estimation of pulmonary vascular resistance. JACC 2003; 41: 1021-1027.
16. Matsumori A, Ohashi N, Hasegawa K, Sasayama S, Eto T, Imaizumi T, Izumi T, Kawamura K, Kawana M, Kimura A. Hepatitis C virüs infection and heart diseases: a multicenter study in Japan. Jpn Circ J 1998; 62: 389-91.
17. Matsumori A. Role of hepatitis C virus in cardiomyopathies. Ernst Schering Res Found Workshop 2006; 99-120.
18. Wang L, Geng J, Li J, Li T, Matsumori A, Chang Y, Lu F, Zhuang H. The biomarker N-terminal pro-brain natriuretic peptide and liver diseases. Clin Invest Med 2011; 34: E30-7.